PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 19,430,000 Shares of Common Stock (par value $0.001 per share) Underwriting AgreementPacific Biosciences of California, Inc. • August 14th, 2020 • Laboratory analytical instruments • New York
Pacific Biosciences of California, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters named in Schedule A (the “Underwriters”) an aggregate of 19,430,000 shares of its common stock, par value $0.001 per share (the “Shares”). The 19,430,000 Shares to be sold by the Company are called the “Firm Shares.” In addition, the Company has granted to the Underwriters an option to purchase up to an additional 2,914,500 Shares. Such additional 2,914,500 Shares to be sold by the Company, if any, pursuant to such option are collectively called the “Optional Shares.” The Firm Shares and, if and to the extent such option is exercised, the Optional Shares, are collectively called the “Offered Shares.” Morgan Stanley & Co. LLC (“Morgan Stanley”) and Cowen and Company, LLC (“Cowen”) have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Offered Shares. To
